Mesco Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Mesco Pharmaceuticals Ltd. on BSE

Search Inside the pdf :

Mesco Pharmaceuticals Ltd.

17 Feb 2022

Result

MESCO PHARMACEUTICALS LTD. - 500274 - Un-Audited Financial Results For The Quarter Ended 31St December, 2021

BSE India

Un-Audited Financial Results for the Quarter ended 31st December, 2021

pdf

Mesco Pharmaceuticals Ltd.

09 Feb 2022, 06:57PM

Board Meeting

MESCO PHARMACEUTICALS LTD. - 500274 - Board Meeting Intimation for The Meeting Of The Board Of …

BSE India

MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve 1. To consider and approve the standalone unaudited financial results for the quarter ended on 31st December, 2021, along with Limited Review Reports. 2. Any other business with the permission of the Chairman.

pdf

Mesco Pharmaceuticals Ltd.

03 Jan 2022

SAST

MESCO PHARMACEUTICALS LTD. - 500274 - Closure of Trading Window

BSE India

As per the Securities and Exchange Board of India (Prohibition of Insider Trading)(Amendment) Regulations, 2018 (including Second Amendment in the said Regulations dated July 25, 2019), the 'Trading restriction period" shall be made applicable from the end of every quarter till 48 hours after the declaration of Financial Results. In view of the aforesaid, it is hereby intimated that the trading window of the Company would be closed with immediate effect i.e. immediately on close of Trading Hours on BSE on Friday, December 31, 2021 and shall be opened on 48 hours after declaration Unaudited Financial Results of the Company for the quarter ended on December 31, 2021 along with along the Limited Review Report thereon.

pdf

Mesco Pharmaceuticals Ltd.

15 Nov 2021

Company Update

Mesco Pharmaceuticals Ltd - 500274 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper publication of Unaudited Financial Results for the Quarter ended 30th September, 2021

pdf

Mesco Pharmaceuticals Ltd.

12 Nov 2021

Result

MESCO PHARMACEUTICALS LTD. - 500274 - Un-Audited Financial Results For The Quarter Ended 30Th September, 2021

BSE India

Un-Audited Financial Quarterly Results with Limited Review Report for 30th September ,2021

pdf

Mesco Pharmaceuticals Ltd.

12 Nov 2021

Board Meeting

MESCO PHARMACEUTICALS LTD. - 500274 - Board Meeting Outcome for Outcome Of Board Meeting Dated 12Th …

BSE India

Considered and approved the Un-Audited Financial Results for Quarter ended on 30th September, 2021 as per Regulation 33(3) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 along with the Limited Review Report.

pdf

Mesco Pharmaceuticals Ltd.

09 Nov 2021, 12:24PM

Company Update

MESCO PHARMACEUTICALS LTD. - 500274 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, please find enclosed the newspaper publication for Board Meeting of the Company to be held on Friday, the 12th November, 2021 .

pdf

Mesco Pharmaceuticals Ltd.

08 Nov 2021

Board Meeting

Mesco Pharmaceuticals Ltd - 500274 - Board Meeting Intimation for Board Meeting Intimation For Consider And …

BSE India

MESCO PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve The standalone unaudited financial results for the quarter ended on 30th September, 2021 along with Limited Review Reports.

pdf

Mesco Pharmaceuticals Ltd.

30 Sep 2021

AGM

MESCO PHARMACEUTICALS LTD. - 500274 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

In terms of Regulation 44(3) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are pleased to submit the Voting Results of the AGM of the Company as required under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with the Scrutinizer''s Report for the 35th AGM held on Wednesday, 29th September, 2021 at Upper Kesalton, Tallital, Nainital-263 001, Uttarakhand commenced at 09.00 A.M. and concluded at 09.55 AM.

pdf

Mesco Pharmaceuticals Ltd.

30 Sep 2021

AGM

MESCO PHARMACEUTICALS LTD. - 500274 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Mesco Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Is Mesco Pharmaceuticals Ltd. worth buying?

2 Votes:

Buy 50.0%

Sell 50.0%